Rna Diagnostics Overview

  • Founded
  • 2010
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 10
Employees
  • Latest Deal Type
  • Later Stage VC
  • Investors
  • 5

Rna Diagnostics General Information

Description

Operator of an early-stage molecular diagnostics company intended to improve the lives of patients undergoing chemotherapy. The company's platform determines the degree of ribosomal RNA (rRNA) disruption which is a biomarker of impending cell death to decide whether the cancer drugs being used are likely or unlikely to benefit the patient, enabling oncologists to avoid harmful side effects and consider for alternate treatments for improving patients survival.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Outcome Management (Healthcare)
Biotechnology
Parent Company
Primary Office
  • 21 Saint Clair Avenue East
  • Suite 701
  • Toronto, Ontario M4T 1L9
  • Canada
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Rna Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Later Stage VC 000 Completed Generating Revenue
11. Later Stage VC (Series A) 08-Nov-2018 000 000 Completed Generating Revenue
10. Merger/Acquisition 00.000 Completed Generating Revenue
9. Later Stage VC 29-Jul-2015 00.000 Completed Generating Revenue
8. Grant 19-Feb-2013 00000 00.000 Completed Generating Revenue
7. Early Stage VC 28-Jan-2013 00.000 Completed Generating Revenue
6. Early Stage VC 14-Mar-2012 00000 00.000 Completed Generating Revenue
5. Corporate 01-Mar-2012 00000 00.000 Completed Generating Revenue
4. Early Stage VC 02-Mar-2011 $304K $1.3M Completed Generating Revenue
3. Grant 01-Jan-2011 $1M Completed Generating Revenue
To view Rna Diagnostics’s complete valuation and funding history, request access »

Rna Diagnostics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of an early-stage molecular diagnostics company intended to improve the lives of patients undergoing chemothera
Diagnostic Equipment
Toronto, Canada
10 As of 2021
000
00000 00000 000

00000000

mod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exerci
0000000000 000000000
Thousand Oaks, CA
00 As of 0000
000.00
0000000000 0 000.00

00000000

t labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris
0000000000 000000000
Cambridge, MA
0000 As of 0000
00000
0.000 0000-00-00
00000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Rna Diagnostics Competitors (18)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
LungLife AI Venture Capital-Backed Thousand Oaks, CA 00 000.00 0000000000 0 000.00
0000000000 0000000 Formerly VC-backed Cambridge, MA 0000 00000 00000000000
00000 Venture Capital-Backed Menlo Park, CA 000 000 000000&0 000
0000 00000000 Venture Capital-Backed San Diego, CA 00 00000 000000 - 000 00000
000000 Venture Capital-Backed Richmond Hill, Canada 00 000.00 000000 - 000 000.00
You’re viewing 5 of 18 competitors. Get the full list »

Rna Diagnostics Executive Team (6)

Name Title Board Seat Contact Info
Amadeo Parissenti Ph.D Chief Scientific Officer
John Connolly Executive Vice President of Corporate Development and Board Member
John Jordan Chief Financial Officer
Kenneth Pritzker MD Senior Advisor
Nick DiPietro Sr. Member, Business Advisory Board
You’re viewing 5 of 6 executive team members. Get the full list »

Rna Diagnostics Board Members (7)

Name Representing Role Since
John Connolly Rna Diagnostics Executive Vice President of Corporate Development and Board Member 000 0000
Paul Lucas Ontario Genomics Board Member 000 0000
Sam Ifergan iGan Partners Board Member 000 0000
You’re viewing 3 of 7 board members. Get the full list »

Rna Diagnostics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Rna Diagnostics Former Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Angel One Investor Network Angel Group Minority 000 0000 000000 0
Georgian Angel Network Angel Group Minority 000 0000 000000 0
Golden Triangle Angelnet Angel Group Minority 000 0000 000000 0
Niagara Angel Network Angel Group Minority 000 0000 000000 0
Northern Ontario Heritage Fund Other Minority 000 0000 000000 0
You’re viewing 5 of 11 investors. Get the full list »